These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 581645)
21. Blockade of audiogenic seizures by bromocryptine. González Pérez JN; González-Quevedo A Pharmacol Biochem Behav; 1980 May; 12(5):823-5. PubMed ID: 7393980 [TBL] [Abstract][Full Text] [Related]
22. [Influence of LSD25 and Deseril on the behaviour and level of biogenic amines in a rat's brain (author's transl)]. Kleinrok Z; Jagiełło-Wójtowicz E; Borzecki Z Ann Univ Mariae Curie Sklodowska Med; 1976; 31():147-54. PubMed ID: 802166 [No Abstract] [Full Text] [Related]
24. Hypophysectomy does not prevent the enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shocks. Nutt DJ; Smith SL; Heal DJ Neuropharmacology; 1982 Sep; 21(9):881-4. PubMed ID: 7145040 [TBL] [Abstract][Full Text] [Related]
25. Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis. Pieri L; Keller HH; Burkard W; Da Prada M Nature; 1978 Mar; 272(5650):278-80. PubMed ID: 203869 [No Abstract] [Full Text] [Related]
26. Inhibition by dopamine agonists of dopamine accumulation following gamma-hydroxybutyrate treatment. Handforth A; Sourkes TL Eur J Pharmacol; 1975 Dec; 34(2):311-9. PubMed ID: 1243993 [TBL] [Abstract][Full Text] [Related]
27. LSD: effect on monoamine metabolites in rat prefrontal cortex. Bowers MB; Salomonsson LA Biochem Pharmacol; 1982 Dec; 31(24):4093-6. PubMed ID: 6186259 [No Abstract] [Full Text] [Related]
28. Dopamine agonist pretreatment alters LSD's electrophysiological action from dopamine agonists to antagonist. Christoph GR; Kuhn DM; Jacobs BL Life Sci; 1978 Nov; 23(21):2099-110. PubMed ID: 31539 [No Abstract] [Full Text] [Related]
29. Facilitation of learned resistance to audiogenic seizures in Balb-cCrgl mice by d-LSD-25. Rouse LO; Frank DL Nature; 1974 Mar; 248(5443):78-81. PubMed ID: 4818566 [No Abstract] [Full Text] [Related]
30. Dopaminergic agonists and their influence on the oxygenation and function activity of underperfused brain tissue. Wiernsperger N; Gygax P; Schweizer A; Danzeisen M Eur J Pharmacol; 1979 Dec; 60(2-3):115-9. PubMed ID: 527654 [TBL] [Abstract][Full Text] [Related]
31. Acute trazodone and quipazine treatment attenuates apomorphine-induced aggressive behaviour in male rats without major impact on emotional behaviour or monoamine content post mortem. Rudissaar R; Pruus K; Vaarmann A; Pannel P; Skrebuhhova-Malmros T; Allikmets L; Matto V Pharmacol Res; 2001 Apr; 43(4):349-58. PubMed ID: 11352540 [TBL] [Abstract][Full Text] [Related]
32. [Changes in the predisposition of rats to audiogenic seizures by intervention in monoamine metabolism]. Katkov IuA Fiziol Zh SSSR Im I M Sechenova; 1984 Apr; 70(4):501-4. PubMed ID: 6145631 [No Abstract] [Full Text] [Related]
33. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists. Green AR; Hall JE; Rees AR Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345 [TBL] [Abstract][Full Text] [Related]
34. The role of dopamine and serotonin in the discriminative stimulus effects of lisuride. White FJ; Appel JB J Pharmacol Exp Ther; 1982 May; 221(2):421-7. PubMed ID: 7077537 [TBL] [Abstract][Full Text] [Related]
35. Effects of glycine, chlorpromazine and apomorphine on brain monoamines and free amino acids in rats. Koyuncuoğlu H; Atamer-Simşek S; Keyer-Uysal M; Sağduyu H Pharmacol Res Commun; 1983 Jan; 15(1):53-61. PubMed ID: 6828543 [No Abstract] [Full Text] [Related]
36. Effects of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline (6-MeO-THbetaC) on audiogenic seizures in DBA/2J mice. Sparks DL; Buckholtz NS Pharmacol Biochem Behav; 1980 Jan; 12(1):119-24. PubMed ID: 6768069 [TBL] [Abstract][Full Text] [Related]
37. Glucose protects DBA/2J mice from audiogenic seizures: correlation with brain glycogen levels. Schreiber RA; Ungar AL Psychopharmacology (Berl); 1984; 84(1):128-31. PubMed ID: 6436881 [TBL] [Abstract][Full Text] [Related]
38. Neuropsychopharmacology of monoamines and their regulatory enzymes. Lipton MA Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941 [No Abstract] [Full Text] [Related]
39. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats. Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731 [TBL] [Abstract][Full Text] [Related]
40. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Johnson AM; Loew DM; Vigouret JM Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]